FDA Inspection 1098419 — CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services

CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services — FEI 1672092

The FDA completed an inspection of CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services on July 11, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 11, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)